Remaining questions on SGLT2 inhibition & CKD: A review of new outcome trials

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

SGLT2 inhibition in kidney disease: key lessons from EMPA-REG OUTCOME
SGLT2 inhibition in kidney disease: key lessons from EMPA-REG OUTCOME
Diabetic Kidney Disease: Exploring mechanisms and outcomes of SGLT2 inhibition
SGLT2 inhibition in kidney disease: key lessons from EMPA-REG OUTCOME
- Prof. Christoph Wanner
Understanding CKD and SGLT2-inhibition: What are the key mechanisms?
Understanding CKD and SGLT2-inhibition: What are the key mechanisms?
Diabetic Kidney Disease: Exploring mechanisms and outcomes of SGLT2 inhibition
Understanding CKD and SGLT2-inhibition: What are the key mechanisms?
- Prof. Per-Henrik Groop